Presentation on Friday 14th June in Trinity Centre for Bioengineering: “Osentia® : A Novel Screening Tool for Fracture Risk”
Mark Towler is our Flaherty Visiting Professor for 2018/19 and is being hosted by the Faculty of Engineering & Computing in Dublin City University. He is from Ryerson University in Toronto, Canada.
During his time in Ireland he is also undertaking laboratory work with Trinity College Dublin (TCD) and will make a presentation in the Trinity Centre for Bioengineering (TCBE) this coming Friday. Details as follows:
Date: Friday, 14th June 2019
Time: 12 noon
Venue: Tercentenary Lecture Theatre, 2nd floor, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2
Title: Osentia® : A Novel Screening Tool for Fracture Risk
Osentia® is sold online (www.osentia.co.uk) and through UK based pharmacies (Gordons Weldrick). Osentia®, invented by Mark Towler (Ryerson University/St Michael’s Hospital, Toronto, Canada), exploits a patented algorithm that combines information around a subject’s protein structure with their clinical risk factors to determine relative risk of fracture. The lecture will consider how Osentia® originated from basic research in Towler’s laboratory through its development in clinical trials emerging as a screening tool launched for over the counter (OTC) testing in 2016.
Further information is available here.